Literature DB >> 6881744

[Hypophosphoremia and meningococcal infection. Preliminary study].

M V Labay Matías, J Bibiloni Sancho, J Reynes Muntaner, M Riesco Prieto, B Gómez Rivas.   

Abstract

Serum phosphorus showing anomaly low values: 2.47 +/- 0.41 mg/dl (p less than 0.001) were determined within the first hours of admittance in 18 children with meningococcal infection. In another 10 renal clearance was performed founding phosphatemias of 2.35 +/- 0.37 mg/dl (p less than 0.002), determining FE of electrolytes. Both groups were compared with another one without infectious pathology which presented normal phosphatemia. Most serious cases had the most severe hypophosphatemia (p less than 0.01); eight children presented hyperphosphaturia up to 52.7 mg/Kg/day and TRP lower than 80%; six asymptomatic hypocalcemia, two hypomagnesemia; FE of potassium was elevated in three children, FE of calcium in one child and FE phosphorus in eight children. Monosodium phosphate was administered to two children with myocarditis as they presented signs of hypophosphatemia. All of them normalized biochemically in 3-4 days. Possible physiopathological mechanisms of this situation are discussed, considering the possibility that hormonal and/or tubular mechanisms take part in the lowering of phosphorus. Necessity of monitoring serum and urine phosphorus in these children is emphasized.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6881744

Source DB:  PubMed          Journal:  An Esp Pediatr        ISSN: 0302-4342


  2 in total

1.  Fulminant meningococcemia and acute renal failure in a 3-year-old boy.

Authors:  Ipek Akil; Hasan Yüksel; Senol Coskun; Dilek Yilmaz; Ali Onag
Journal:  Pediatr Nephrol       Date:  2003-11-25       Impact factor: 3.714

2.  Acute kidney injury in a mouse model of meningococcal disease.

Authors:  Karin R Kolbe; Talita R Sanches; Camilla Fanelli; Margoth R Garnica; Letícia Urbano de Castro; Karen Gooch; Stephen Thomas; Stephen Taylor; Andrew Gorringe; Irene de L Noronha; Lucia Andrade
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.